Simultaneous Pseudoprogression and an Immune-related Adverse Event of Pulmonary Pleomorphic Carcinoma after Combined Therapy with Cytotoxic Anticancer Agents and Immune Checkpoint Inhibitor

Pulmonary pleomorphic carcinoma is rare among lung tumors. Pulmonary pleomorphic carcinoma is resistant to chemotherapy. However, treatment with taxane anticancer agents and immune checkpoint inhibitors has been reported to be effective. When using immune checkpoint inhibitors, pseudoprogression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Murao, Koutaro, Mori, Yuki, Takahashi, Yukino, Ishikawa, Tatsuru, Asai, Yuichiro, Kobayashi, Tomofumi, Ikeda, Kimiyuki, Kuronuma, Koji, Magara, Kazufumi, Fujita, Hiromi, Hirohashi, Yoshihiko, Takasawa, Akira, Chiba, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683815/
https://www.ncbi.nlm.nih.gov/pubmed/35400698
http://dx.doi.org/10.2169/internalmedicine.8916-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683815/
https://www.ncbi.nlm.nih.gov/pubmed/35400698
http://dx.doi.org/10.2169/internalmedicine.8916-21

Ejemplares similares